Belgian innovative pharma sector urges government to prioritise competitiveness

EURACTIV - The Belgian innovative pharmaceutical industry continues to grow, but competitiveness dynamics and EU pharma package revisions are causing uncertainty. Euractiv spoke in depth with Caroline Ven, CEO of pharma.be, about the sector's concerns. Read more

Caroline Ven, CEO of pharma.be